Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Duo to Nonresponse to Standard Therapy

NCT04376528 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT04376528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04376528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Duo to Nonresponse to Standard Therapy
Lead sponsor
West China Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
June 16, 2021
Completion date
December 30, 2021
Enrollment
89 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis, autoimmune, immunosuppression, primary biliary cholangitis